Signed a Research Collaboration Agreement (RCA) with BioNet-Asia

Pharmaniaga LifeScience Sdn Bhd (PLS), a wholly-owned subsidiary of Pharmaniaga Berhad, today signed a Research Collaboration Agreement (RCA) with BioNet-Asia Co. Ltd (BioNet) of Thailand for the development of a 6-in-1 combination vaccine (Hexavalent vaccine) for children’s healthcare, using BioNet formulation. This initiative is in line with Pharmaniaga’s plan of establishing the world’s first Halal vaccine plant. The production of vaccines locally will reduce costs for the Government as well as to ensure drug security for the nation against any future pandemic threats. The RCA was signed by Pharmaniaga Group Managing Director Datuk Zulkarnain Md Eusope and BioNet Group President Mr Vitoon Vonghangool; and witnessed by Pharmaniaga Chairman Datuk Seri Zainal Abidin Mohd Rafique and BioNet Chief Executive Officer Dr Hong Thai Pham.